Your browser doesn't support javascript.
loading
Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels.
Ur Rehman, Naeem; Abbas, Muzaffar; Al-Rashida, Mariya; Tokhi, Ahmed; Arshid, Muhammad Awais; Khan, Muhammad Sona; Ahmad, Izhar; Rauf, Khalid.
Afiliación
  • Ur Rehman N; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
  • Abbas M; Department of Pharmacy, Capital University of Science and Technology (CUST), Islamabad, Pakistan.
  • Al-Rashida M; Department of Chemistry, Forman Christian College (A Chartered University), Lahore 54600, Pakistan.
  • Tokhi A; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
  • Arshid MA; Aga Khan University, Karachi, Pakistan.
  • Khan MS; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
  • Ahmad I; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
  • Rauf K; Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Islamabad, Pakistan.
Drug Des Devel Ther ; 14: 3777-3786, 2020.
Article en En | MEDLINE | ID: mdl-32982182
ABSTRACT

INTRODUCTION:

Behavioral sensitization is a phenomenon that develops from intermittent exposure to nicotine and other psychostimulants, which often leads to heightened locomotor activity and then relapse. Sulfonamides that act as carbonic anhydrase inhibitors have a documented role in enhancing dopaminergic tone and normalizing neuroplasticity by stabilizing glutamate release.

OBJECTIVE:

The aim of the current study was to explore synthetic sulfonamides derivative 4-fluoro-N-(4-sulfamoylbenzyl) benzene-sulfonamide (4-FBS) (with documented carbonic anhydrase inhibitory activity) on acquisition and expression of nicotine-induced behavioral sensitization.

METHODS:

In the acquisition phase, selected 5 groups of mice were exposed to saline or nicotine 0.5mg/kg intraperitoneal (i.p) for 7 consecutive days. Selected 3 groups were administered with 4-FBS 20, 40, and 60 mg/kg p.o. along with nicotine. After 3 days of the drug-free period, ie, day 11, a challenge dose of nicotine was injected to all groups except saline and locomotor activity was recorded for 30 minutes. In the expression phase, mice were exposed to saline and nicotine only 0.5 mg/kg i.p for 7 consecutive days. After 3 days of the drug-free period, ie, day 11, 4-FBS at 20, 40, and 60 mg/kg were administered to the selected groups, one hour after drug a nicotine challenge dose was administered, and locomotion was recorded. At the end of behavioral experiments, all animals were decapitated and the striatum was excised and screened for changes in adenosine levels, using HPLC-UV.

RESULTS:

Taken together, our findings showed that 4-FBS in all 3 doses, in both sets of experiments significantly attenuated nicotine-induced behavioral sensitization in mice. Additionally, 4-FBS at 60mg/kg significantly lowered the adenosine level in the striatum.

CONCLUSION:

The behavioral and adenosine modulation is promising, and more receptors level studies are warranted to explore the exact mechanism of action of 4-FBS.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sulfonamidas / Conducta Animal / Derivados del Benceno / Adenosina / Antagonistas Nicotínicos / Nicotina Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sulfonamidas / Conducta Animal / Derivados del Benceno / Adenosina / Antagonistas Nicotínicos / Nicotina Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article